Filings

Finds words inside filing documents. Searching Petros Pharmaceuticals, Inc.'s filings · 15 documents indexed.

7 documents · 15 matches

PTPI Petros Pharmaceuticals, Inc. 10-K 2026-04-15

Item 1A. Risk Factors
material weaknesses and strengthening the internal control environment will require a substantial effort, as necessary, and Petros will test the ongoing
9 matches in this document
PTPI Petros Pharmaceuticals, Inc. 10-Q 2026-08-13

Item 4. Controls and Procedures.
material weakness is a control deficiency (within the meaning of Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 5) or combination
1 match in this document
PTPI Petros Pharmaceuticals, Inc. 10-Q 2026-05-13

Item 4. Controls and Procedures.
material weakness is a control deficiency (within the meaning of Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 5) or combination
1 match in this document
PTPI Petros Pharmaceuticals, Inc. 10-Q 2025-11-13

Item 4. Controls and Procedures.
material weakness is a control deficiency (within the meaning of Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 5) or combination
1 match in this document
PTPI Petros Pharmaceuticals, Inc. 10-Q 2025-08-14

Item 4. Controls and Procedures.
material weakness is a control deficiency (within the meaning of Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 5) or combination
1 match in this document
PTPI Petros Pharmaceuticals, Inc. 10-Q 2025-05-15

Item 4. Controls and Procedures.
material weakness is a control deficiency (within the meaning of Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 5) or combination
1 match in this document
PTPI Petros Pharmaceuticals, Inc. 8-K 2025-09-05

Item 4.01. Changes in Registrant’s Certifying Accountant.
material weakness in the Company’s internal control over financial reporting due to a deficiency relating to the Company’s insufficient
1 match in this document

Page 1 of 1 · 7 documents